AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BATM Advanced Communications Ltd.

Pre-Annual General Meeting Information Nov 14, 2024

6682_agm-r_2024-11-14_7e685d98-78a0-423d-b908-4059ad26cbbb.html

Pre-Annual General Meeting Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2814M

BATM Advanced Communications Ld

14 November 2024

LEI:  213800FLQUB9J289RU66

14 November 2024

BATM Advanced Communications Limited

("BATM" or "the Group")  

Notice of Annual General Meeting and

Proposed Director Appointment

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, gives notice that the Annual General Meeting ("AGM" or the "Meeting") of the Group is to be held at 12.00pm Israel time (10.00am UK time) on 19 December 2024 at the Group's registered office at 4 Ha'harash Street, Nave Ne'eman Industrial Area, P.O.B. 7318, 4524075 Hod Hasharon, Israel.

In order to enable shareholder engagement and participation for those unable to physically attend the Meeting, shareholders will be able to access the Meeting via videoconference.

Among the resolutions to be proposed to the AGM is a resolution appointing Dr. Shmuel (Muli) Ben-Zvi as a Non-executive Director of the Group to take effect from the conclusion of the Meeting.

Dr. Shmuel (Muli) Ben Zvi was elected Chairman of the board of Bank Leumi, the largest banking corporation in Israel, in October 2023 for the final year of his nine-year tenure as a director. At Bank Leumi, he was a member of the board's audit, risk management, credit, technology and strategy committees. Dr. Ben Zvi has extensive executive and board experience across multiple industries, including currently being a director of Protalix Biotherapeutics (NYSE American: PLX) and previously of Sol-Gel Technologies (NASDAQ: SLGL) and VBL Therapeutics (NASDAQ: VBLT). From 2004 to 2014, he held a number of managerial positions at Teva Pharmaceuticals (NASDAQ and TASE: TEVA), including Vice President of Strategy and Vice President of Finance.

In accordance with Israeli Companies Law, the Group requires shareholder approval to appoint a new Non-executive Director. The required disclosures pursuant to UK Listing Rules 6.4.8 in relation to Dr. Ben Zvi will be made in due course subject to his appointment.

Further information on the resolutions, notes and details on how to attend the AGM via videoconference can be found in the Notice of AGM that, along with forms of proxy and direction, has today been made available on BATM's website at:  www.batm.com .  

Enquiries

BATM Advanced Communications
Moti Nagar, Chief Executive Officer +972 9866 2525
Ran Noy, Chief Financial Officer
Shore Capital
Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory) +44 20 7408 4050
Gracechurch Group
Harry Chathli, Claire Norbury +44 20 4582 3500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOABZLFFZFLZFBB

Talk to a Data Expert

Have a question? We'll get back to you promptly.